Nonetheless, new triglyceride-lowering treatments targeting angiopoietin-like 3 (lipoprotein lipase inhibitor) and apolipoprotein C3 antisense will add further insights into the role of triglycerides in the progression of atherosclerosis [16]. Here, ANGPTL3 is linked to atherosclerosis.